Global Interleukin 12 Receptor Market Research Report 2023

Report ID: 1969837 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Interleukin 12 Receptor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Edodekin Alfa SR
        1.2.3 M-9241
        1.2.4 LY-3232094
        1.2.5 NMIL-121
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Interleukin 12 Receptor Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 In-Patient
        1.3.3 Out-Patient
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Interleukin 12 Receptor Market Perspective (2017-2028)
    2.2 Interleukin 12 Receptor Growth Trends by Region
        2.2.1 Interleukin 12 Receptor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Interleukin 12 Receptor Historic Market Size by Region (2017-2022)
        2.2.3 Interleukin 12 Receptor Forecasted Market Size by Region (2023-2028)
    2.3 Interleukin 12 Receptor Market Dynamics
        2.3.1 Interleukin 12 Receptor Industry Trends
        2.3.2 Interleukin 12 Receptor Market Drivers
        2.3.3 Interleukin 12 Receptor Market Challenges
        2.3.4 Interleukin 12 Receptor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Interleukin 12 Receptor Players by Revenue
        3.1.1 Global Top Interleukin 12 Receptor Players by Revenue (2017-2022)
        3.1.2 Global Interleukin 12 Receptor Revenue Market Share by Players (2017-2022)
    3.2 Global Interleukin 12 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Interleukin 12 Receptor Revenue
    3.4 Global Interleukin 12 Receptor Market Concentration Ratio
        3.4.1 Global Interleukin 12 Receptor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Interleukin 12 Receptor Revenue in 2021
    3.5 Interleukin 12 Receptor Key Players Head office and Area Served
    3.6 Key Players Interleukin 12 Receptor Product Solution and Service
    3.7 Date of Enter into Interleukin 12 Receptor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Interleukin 12 Receptor Breakdown Data by Type
    4.1 Global Interleukin 12 Receptor Historic Market Size by Type (2017-2022)
    4.2 Global Interleukin 12 Receptor Forecasted Market Size by Type (2023-2028)
5 Interleukin 12 Receptor Breakdown Data by Application
    5.1 Global Interleukin 12 Receptor Historic Market Size by Application (2017-2022)
    5.2 Global Interleukin 12 Receptor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Interleukin 12 Receptor Market Size (2017-2028)
    6.2 North America Interleukin 12 Receptor Market Size by Country (2017-2022)
    6.3 North America Interleukin 12 Receptor Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Interleukin 12 Receptor Market Size (2017-2028)
    7.2 Europe Interleukin 12 Receptor Market Size by Country (2017-2022)
    7.3 Europe Interleukin 12 Receptor Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Interleukin 12 Receptor Market Size (2017-2028)
    8.2 Asia-Pacific Interleukin 12 Receptor Market Size by Country (2017-2022)
    8.3 Asia-Pacific Interleukin 12 Receptor Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Interleukin 12 Receptor Market Size (2017-2028)
    9.2 Latin America Interleukin 12 Receptor Market Size by Country (2017-2022)
    9.3 Latin America Interleukin 12 Receptor Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Interleukin 12 Receptor Market Size (2017-2028)
    10.2 Middle East & Africa Interleukin 12 Receptor Market Size by Country (2017-2022)
    10.3 Middle East & Africa Interleukin 12 Receptor Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Company Detail
        11.1.2 Eli Lilly and Company Business Overview
        11.1.3 Eli Lilly and Company Interleukin 12 Receptor Introduction
        11.1.4 Eli Lilly and Company Revenue in Interleukin 12 Receptor Business (2017-2022)
        11.1.5 Eli Lilly and Company Recent Development
    11.2 Mallinckrodt Plc
        11.2.1 Mallinckrodt Plc Company Detail
        11.2.2 Mallinckrodt Plc Business Overview
        11.2.3 Mallinckrodt Plc Interleukin 12 Receptor Introduction
        11.2.4 Mallinckrodt Plc Revenue in Interleukin 12 Receptor Business (2017-2022)
        11.2.5 Mallinckrodt Plc Recent Development
    11.3 Merck KGaA
        11.3.1 Merck KGaA Company Detail
        11.3.2 Merck KGaA Business Overview
        11.3.3 Merck KGaA Interleukin 12 Receptor Introduction
        11.3.4 Merck KGaA Revenue in Interleukin 12 Receptor Business (2017-2022)
        11.3.5 Merck KGaA Recent Development
    11.4 Neumedicines Inc
        11.4.1 Neumedicines Inc Company Detail
        11.4.2 Neumedicines Inc Business Overview
        11.4.3 Neumedicines Inc Interleukin 12 Receptor Introduction
        11.4.4 Neumedicines Inc Revenue in Interleukin 12 Receptor Business (2017-2022)
        11.4.5 Neumedicines Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Interleukin 12 Receptor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Edodekin Alfa SR
    Table 3. Key Players of M-9241
    Table 4. Key Players of LY-3232094
    Table 5. Key Players of NMIL-121
    Table 6. Key Players of Others
    Table 7. Global Interleukin 12 Receptor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Interleukin 12 Receptor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Interleukin 12 Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Interleukin 12 Receptor Market Share by Region (2017-2022)
    Table 11. Global Interleukin 12 Receptor Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Interleukin 12 Receptor Market Share by Region (2023-2028)
    Table 13. Interleukin 12 Receptor Market Trends
    Table 14. Interleukin 12 Receptor Market Drivers
    Table 15. Interleukin 12 Receptor Market Challenges
    Table 16. Interleukin 12 Receptor Market Restraints
    Table 17. Global Interleukin 12 Receptor Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Interleukin 12 Receptor Market Share by Players (2017-2022)
    Table 19. Global Top Interleukin 12 Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 12 Receptor as of 2021)
    Table 20. Ranking of Global Top Interleukin 12 Receptor Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Interleukin 12 Receptor Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Interleukin 12 Receptor Product Solution and Service
    Table 24. Date of Enter into Interleukin 12 Receptor Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Interleukin 12 Receptor Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Interleukin 12 Receptor Revenue Market Share by Type (2017-2022)
    Table 28. Global Interleukin 12 Receptor Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Interleukin 12 Receptor Revenue Market Share by Type (2023-2028)
    Table 30. Global Interleukin 12 Receptor Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Interleukin 12 Receptor Revenue Market Share by Application (2017-2022)
    Table 32. Global Interleukin 12 Receptor Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Interleukin 12 Receptor Revenue Market Share by Application (2023-2028)
    Table 34. North America Interleukin 12 Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Interleukin 12 Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Interleukin 12 Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Interleukin 12 Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Interleukin 12 Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Interleukin 12 Receptor Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Interleukin 12 Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Interleukin 12 Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Interleukin 12 Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Interleukin 12 Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Eli Lilly and Company Company Detail
    Table 45. Eli Lilly and Company Business Overview
    Table 46. Eli Lilly and Company Interleukin 12 Receptor Product
    Table 47. Eli Lilly and Company Revenue in Interleukin 12 Receptor Business (2017-2022) & (US$ Million)
    Table 48. Eli Lilly and Company Recent Development
    Table 49. Mallinckrodt Plc Company Detail
    Table 50. Mallinckrodt Plc Business Overview
    Table 51. Mallinckrodt Plc Interleukin 12 Receptor Product
    Table 52. Mallinckrodt Plc Revenue in Interleukin 12 Receptor Business (2017-2022) & (US$ Million)
    Table 53. Mallinckrodt Plc Recent Development
    Table 54. Merck KGaA Company Detail
    Table 55. Merck KGaA Business Overview
    Table 56. Merck KGaA Interleukin 12 Receptor Product
    Table 57. Merck KGaA Revenue in Interleukin 12 Receptor Business (2017-2022) & (US$ Million)
    Table 58. Merck KGaA Recent Development
    Table 59. Neumedicines Inc Company Detail
    Table 60. Neumedicines Inc Business Overview
    Table 61. Neumedicines Inc Interleukin 12 Receptor Product
    Table 62. Neumedicines Inc Revenue in Interleukin 12 Receptor Business (2017-2022) & (US$ Million)
    Table 63. Neumedicines Inc Recent Development
    Table 64. Research Programs/Design for This Report
    Table 65. Key Data Information from Secondary Sources
    Table 66. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Interleukin 12 Receptor Market Share by Type: 2021 VS 2028
    Figure 2. Edodekin Alfa SR Features
    Figure 3. M-9241 Features
    Figure 4. LY-3232094 Features
    Figure 5. NMIL-121 Features
    Figure 6. Others Features
    Figure 7. Global Interleukin 12 Receptor Market Share by Application in 2021 & 2028
    Figure 8. In-Patient Case Studies
    Figure 9. Out-Patient Case Studies
    Figure 10. Interleukin 12 Receptor Report Years Considered
    Figure 11. Global Interleukin 12 Receptor Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Interleukin 12 Receptor Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Interleukin 12 Receptor Market Share by Region: 2021 VS 2028
    Figure 14. Global Interleukin 12 Receptor Market Share by Players in 2021
    Figure 15. Global Top Interleukin 12 Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 12 Receptor as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Interleukin 12 Receptor Revenue in 2021
    Figure 17. North America Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Interleukin 12 Receptor Market Share by Country (2017-2028)
    Figure 19. United States Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Interleukin 12 Receptor Market Share by Country (2017-2028)
    Figure 23. Germany Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Interleukin 12 Receptor Market Share by Region (2017-2028)
    Figure 31. China Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Interleukin 12 Receptor Market Share by Country (2017-2028)
    Figure 39. Mexico Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Interleukin 12 Receptor Market Share by Country (2017-2028)
    Figure 43. Turkey Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Interleukin 12 Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Eli Lilly and Company Revenue Growth Rate in Interleukin 12 Receptor Business (2017-2022)
    Figure 46. Mallinckrodt Plc Revenue Growth Rate in Interleukin 12 Receptor Business (2017-2022)
    Figure 47. Merck KGaA Revenue Growth Rate in Interleukin 12 Receptor Business (2017-2022)
    Figure 48. Neumedicines Inc Revenue Growth Rate in Interleukin 12 Receptor Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly and Company
Mallinckrodt Plc
Merck KGaA
Neumedicines Inc
Frequently Asked Questions
Interleukin 12 Receptor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Interleukin 12 Receptor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Interleukin 12 Receptor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hemagglutinin 5

Hemagglutinin 5 market is segmented by players, region (country), by Type and by Application. Pla ... Read More

Celiac Disease Drug

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Tablet Touch Pen

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More